MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma
Gordon Cook,Elena Zamagni,Mario Boccadoro,Andrew Spencer,Michel Delforge,Donna Reece, Agoston Gyula Szabo,Hermann Einsele,Evangelos Terpos,Fredrik Schjesvold,Jelena Bila,Christoph Driessen,Meral Beksac, Cesar Rodriguez,Lixia Pei, Yingqi Shi,Caline Sakabedoyan, Jagaoda Jasielec,Himal Amin,Rachel Kobos,Pieter Sonneveld,Niels Van De Donk BRITISH JOURNAL OF HAEMATOLOGY(2023)
AI 理解论文
溯源树
样例